Category : Healthcare and Pharmaceutical

Workforce Development & Leadership

Matter Neuroscience Partners with Stanford for fMRI Neurofeedback in Depression

PR Newswire
by PR Newswire0219
This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. Matter Neuroscience...
Healthcare Infrastructure, Operations & Supply Chain

SCIEX & Evosep Expand Proteomics Access via New Reseller Deal

Business Wire
by Business Wire0243
SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), and Evosep Biosystems, a global leader in proteomics solutions,...
Clinical Research, Pharma & Healthcare Financing

ImmunAbs Gets FDA Phase 2 IND OK for IM-101 in Myasthenia Gravis

Business Wire
by Business Wire0193
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug...
Healthcare Quality, Patient Safety & Policy

KalVista Highlights Sebetralstat’s Potential at Medical Congress

Business Wire
by Business Wire0267
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new setralstat findings related to time to end of progression of hereditary angioedema (HAE) attacks, and the effectiveness...
Digital Health, Technology & Innovation

SCIEX Launches ZenoTOF 8600 for Accurate Mass Quantitation

Business Wire
by Business Wire0232
At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), launches the ZenoTOF 8600 system, setting a...
Clinical Research, Pharma & Healthcare Financing

Bruker Unveils timsUltra AIP with Extreme Sensitivity for Proteomics

Business Wire
by Business Wire0187
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics At the 73rd Conference on Mass...
Healthcare Quality, Patient Safety & Policy

Astellas, Evopoint Ink Deal for CLDN18.2 ADC XNW27011

PR Newswire
by PR Newswire0197
Agreement grants Astellas exclusive worldwide rights (excluding China’s mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW27011 XNW27011 has demonstrated encouraging monotherapy efficacy in an ongoing Phase 1/2 study...
Clinical Research, Pharma & Healthcare Financing

BioVaxys, Horizon Amend Asset Purchase Agreement

PR Newswire
by PR Newswire0201
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets BioVaxys Technology Corp. is pleased to announce today that the Company and Horizon...